National Conference of the Italian Group for the Study of Neuromorphology
Vol. 70 No. s2 (2026): 36th National Conference of the Italian Group for the Study of...

OC01 | MAPPING THE ENTERIC NERVOUS SYSTEM IN SEVERE GASTROINTESTINAL DYSMOTILITY: NEURONAL AND GLIAL MORPHOMETRY

E. Boschetti1, S. Blando1, H. Yagi1, I. Neri1, B. Ohlsson2, C. Malagelada3, L. Manzoli1, R. De Giorgio4, S. Ratti1 | 1Cellular Signalling Laboratory, Anatomy Center, Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Italy; 2Internal Medicine–Epidemiology, Department of Clinical Sciences Malmö, Faculty of Medicine, Lund University, Sweden; 3Digestive System Research Unit, University Hospital Vall d'Hebron, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (Ciberehd), Spain; 4Department of Translational Medicine, University of Ferrara, Italy

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 20 November 2026
0
Views
0
Downloads

Authors

Background and aims. Histopathological assessment of the enteric nervous system (ENS) remains largely qualitative and observer-dependent. We investigated whether arbitrary ganglionic units (AGUs) [1] provide a practical quantitative approach for identifying enteric neuropathy and help to develop a stepwise diagnostic algorithm for severe enteric dysmotility (SD).
Methods. Full-thickness jejunal specimens from 34 patients with SD and 9 controls were analyzed after pan-neuronal immunostaining. In two-dimensional sections, immunoreactive neurons separated by less than 300 μm were assigned to the same AGU. AGU density was expressed as AGUs/mm of neuromuscular ridge. Interganglionic distance, AGU area, and neuronal number were also assessed. Glial cells/AGU were quantified in a subgroup of patients and controls. Preliminary diagnostic ranges were defined through exploratory ROC and distribution-based analyses.
Results. AGU density, but not area, distinguished SD patients from controls (P<0.0001). An AGU density below 0.90 AGU/mm identified 85.3% of patients and none of controls, hence being classified as pathological. Values between 0.90 and <1.0 AGU/mm defined a borderline range and included 5.9% of patients, whereas values ≥1.0 AGU/mm were observed in 8.8% of patients. Four additional patients, not classified as pathological on AGU density, were identified by an increased interganglionic distance. Thus, the first two steps of the algorithm provided evidence of ENS neuropathy in 97.1% of patients. The remaining 2.9% required neuronal counting/AGU as the final diagnostic step. Glial cells/AGU did not show differences between groups, despite a lower neuron-to-glia ratio in SD.
Conclusions. AGU density provides a simple first-line quantitative assessment of jejunal ENS organization. We propose a hierarchical algorithm using AGU density cutoff of 0.90 AGU/mm, followed by interganglionic distance and, only in cases unresolved by both parameters, neuronal counting. These preliminary findings require validation in larger cohorts, while more stringent thresholds are being evaluated to optimize diagnostic specificity.

Downloads

Download data is not yet available.

Citations

1. Boschetti E, et al. Am J Physiol Gastrointest Liver Physiol 2019; 317: G793-G801.

How to Cite



1.
OC01 | MAPPING THE ENTERIC NERVOUS SYSTEM IN SEVERE GASTROINTESTINAL DYSMOTILITY: NEURONAL AND GLIAL MORPHOMETRY: E. Boschetti1, S. Blando1, H. Yagi1, I. Neri1, B. Ohlsson2, C. Malagelada3, L. Manzoli1, R. De Giorgio4, S. Ratti1 | 1Cellular Signalling Laboratory, Anatomy Center, Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Italy; 2Internal Medicine–Epidemiology, Department of Clinical Sciences Malmö, Faculty of Medicine, Lund University, Sweden; 3Digestive System Research Unit, University Hospital Vall d’Hebron, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (Ciberehd), Spain; 4Department of Translational Medicine, University of Ferrara, Italy. Eur J Histochem [Internet]. 2026 Nov. 20 [cited 2026 Nov. 20];70(s2). Available from: https://www.ejh.it/ejh/article/view/4795